Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women

被引:17
作者
Andréoletti, L
Chomont, N
Grésenguet, G
Matta, M
Longo, JD
Carreno, MP
Si-Mohamed, A
Legoff, J
Kazatchkine, MD
Bélec, L
机构
[1] Ctr Hosp Univ, Virol Lab, Reims, France
[2] Hop Broussais, INSERM, U430, F-75674 Paris, France
[3] Hop Europeen Georges Pompidou, Virol Lab, Paris, France
[4] Univ Paris 06, Paris, France
[5] MST & SIDA, Fac Sci Sante, Unite Rech & Intervent, Bangui, Cent Afr Republ
[6] Ctr Natl Reference Malad Sexuellement Transmissib, Bangui, Cent Afr Republ
关键词
D O I
10.1086/377104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Using ultrasensitive polymerase chain reaction-based techniques, we assessed levels of cell-free and cell-associated human immunodeficiency virus (HIV)-1 in paired blood and genital samples of 30 clinically asymptomatic, treatment-naive women. Levels of HIV-1 RNA in cervicovaginal-lavage samples were positively correlated with those in plasma samples (r = .50; P = .008), whereas levels of HIV-1 DNA in genital samples were loosely correlated with those in blood samples (r = .31; P = .041). In plasma of peripheral blood, levels of HIV-1 DNA were positively correlated with those of HIV-1 RNA (r = .64; P < .001), whereas no correlation between HIV-1 DNA and HIV-1 RNA was evident in genital secretions. Our results indicate that levels of HIV-1 RNA and HIV-1 DNA are unrelated in the genital tracts of treatment-naive women and suggest that the level of genital HIV-1 RNA is influenced by systemic viral replication-in contrast to genital HIV-1 provirus, which may be influenced as well by local cofactors triggering the migration of HIV-infected cells originating from the cervicovaginal submucosa. These features may be relevant for an understanding of HIV-1 transmission in heterosexual individuals.
引用
收藏
页码:549 / 554
页数:6
相关论文
共 15 条
[1]  
BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57
[2]   Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid:: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding [J].
Chomont, N ;
Grésenguet, G ;
Hocini, H ;
Becquart, P ;
Matta, M ;
Andreoletti, L ;
Si-Mohamed, A ;
Carreno, MP ;
Kazatchkine, M ;
Bélec, L .
AIDS, 2001, 15 (06) :801-802
[3]   Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission [J].
Chuachoowong, R ;
Shaffer, N ;
Siriwasin, W ;
Chaisilwattana, P ;
Young, NL ;
Mock, PA ;
Chearskul, S ;
Waranawat, N ;
Chaowanachan, T ;
Karon, J ;
Simonds, RJ ;
Mastro, TD .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :99-106
[4]   Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract [J].
Hart, CE ;
Lennox, JL ;
Pratt-Palmore, M ;
Wright, TC ;
Schinazi, RF ;
Evans-Strickfaden, T ;
Bush, TJ ;
Schnell, C ;
Conley, LJ ;
Clancy, KA ;
Ellerbrock, TV .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :871-882
[5]   Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions [J].
Iversen, AKN ;
Larsen, AR ;
Jensen, T ;
Fugger, L ;
Balslev, U ;
Wahl, S ;
Gerstoft, J ;
Mullins, JI ;
Skinhoj, P .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1214-1220
[6]  
Kovacs A, 1999, J ACQ IMMUN DEF SYND, V22, P124
[7]   Determinants of HIV-1 shedding in the genital tract of women [J].
Kovacs, A ;
Wasserman, SS ;
Burns, D ;
Wright, DJ ;
Cohn, J ;
Landay, A ;
Weber, K ;
Cohen, M ;
Levine, A ;
Minkoff, H ;
Miotti, P ;
Palefsky, J ;
Young, M ;
Reichelderfer, P .
LANCET, 2001, 358 (9293) :1593-1601
[8]   Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women:: Opportunities for intervention [J].
Mbopi-Kéou, FX ;
Grésenguet, G ;
Mayaud, P ;
Weiss, HA ;
Gopal, R ;
Matta, M ;
Paul, JL ;
Brown, DWG ;
Hayes, RJ ;
Mabey, DCW ;
Bélec, L .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1090-1096
[9]   Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes [J].
Michael, NL ;
Herman, SA ;
Kwok, S ;
Dreyer, K ;
Wang, J ;
Christopherson, C ;
Spadoro, JP ;
Young, KKY ;
Polonis, V ;
McCutchan, FE ;
Carr, J ;
Mascola, JR ;
Jagodzinsi, LL ;
Robb, ML .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (08) :2557-2563
[10]  
NUOVO GJ, 1993, AM J PATHOL, V143, P40